Telomere shortening in leukocyte subpopulations in depression

BMC Psychiatry

Volumn 14, Issue 1, 2014, Pages

  Karabatsiakis, Alexander ^a   Kolassa, Iris Tatjana ^a   Kolassa, Stephan ^b   Rudolph, K L ^c   Dietrich, Detlef E ^d,e  

^a UNIVERSITY OF ULM   (Germany)

^b SAP Switzerland ^*  (Switzerland)

^c FRITZ LIPMANN INSTITUTE   (Germany)

^d Burghof Klinik   (Germany)

^e HANNOVER MEDICAL SCHOOL   (Germany)

Author keywords

Aging; Depression; Immunosenescence; Stress; Telomere shortening

Indexed keywords

CD20 ANTIGEN; LEVOTHYROXINE; SEROTONIN NORADRENALIN REUPTAKE INHIBITOR; SEROTONIN UPTAKE INHIBITOR; ANTIDEPRESSANT AGENT;

ADAPTIVE IMMUNITY; ADULT; ARTICLE; B LYMPHOCYTE; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CLINICAL ARTICLE; CONTROLLED STUDY; DEPRESSION; FEMALE; FLUORESCENCE IN SITU HYBRIDIZATION; HELPER CELL; HUMAN; HYPERTENSION; LYMPHOCYTE SUBPOPULATION; PSYCHOPHARMACOTHERAPY; TELOMERE SHORTENING; GENETICS; LEUKOCYTE; MONONUCLEAR CELL; RISK; TELOMERE; AGED; BECK DEPRESSION INVENTORY; CD20+ B LYMPHOCYTE; CD4+ HELPER CELL; CD8+ CYTOTOXIC T LYMPHOCYTE; CELL POPULATION; CLINICAL ASSESSMENT; COMPARATIVE STUDY; FLUORESCENCE MICROSCOPY; MAJOR DEPRESSION; TELOMERE HOMEOSTASIS;

ADULT; CD8-POSITIVE T-LYMPHOCYTES; DEPRESSIVE DISORDER; FEMALE; HUMANS; IN SITU HYBRIDIZATION, FLUORESCENCE; LEUKOCYTES; LEUKOCYTES, MONONUCLEAR; RISK; TELOMERE; TELOMERE SHORTENING;

EID: 84924034183     PISSN: None     EISSN: 1471244X     Source Type: Journal    
DOI: 10.1186/1471-244X-14-192     Document Type: Article

References (40)

1. Epel ES, Merkin SS, Cawthon R, Blackburn EH, Adler NE, Pletcher MJ. The rate of leukocyte telomere shortening predicts mortality from cardiovascular disease in elderly men. Aging 2008, 1:81-88.
2. Massie M, Lloyd-Williams M. The prevalence of depression in people with cancer. J Natl Cancer Inst 2011, 32:57-71.
3. Von Zglinicki T, Martin-Ruiz CM. Telomeres as biomarkers for ageing and age-related diseases. Curr Mol Med 2005, 5:197-203.
4. Son NH, Murray S, Yanovski J, Hodes RJ, Weng N. Lineage-specific telomere shortening and unaltered capacity for telomerase expression in human T and B lymphocytes with age. J Immunol 2000, 165:1191-1196.
5. Willeit P, Willeit J, Mayr A, Weger S, Oberhollenzer F, Brandstätter A. Telomere length and risk of incident cancer and cancer mortality. JAMA 2010, 304:69-75.
6. Kotrschal A, Ilmonen P, Penn DJ. Stress impacts telomere dynamics. Biology Lett 2007, 3:128-130.
7. O'Donovan A, Lin J, Dhabhar FS, Wolkowitz O, Tillie JM, Blackburn E. Pessimism correlates with leukocyte telomere shortness and elevated interleukin-6 in post-menopausal women. Brain Behav Immun 2009, 23:446-449.
8. O'Donovan A, Epel E, Lin J, Wolkowitz O, Cohen B, Maguen S. Childhood trauma associated with short leukocyte telomere length in posttraumatic stress disorder. Biol Psychiat 2011, 70:465-471.
9. Drury SS, Theall K, Gleason MM, Smyke AT, De Vivo I, Wong JYY. Telomere length and early severe social deprivation: linking early adversity and cellular aging. Mol Psychiatr 2011, 17:719-727.
10. Simon NM, Smoller JW, McNamara KL, Maser RS, Zalta AK, Pollack MH. Telomere shortening and mood disorders: preliminary support for a chronic stress model of accelerated aging. Biol Psychiat 2006, 60:432-435.
11. Wikgren M, Maripuu M, Karlsson T, Nordfjäll K, Bergdahl J, Hultdin J. Short telomeres in depression and the general population are associated with a hypocortisolemic state. Biol Psychiat 2012, 71:294-300.
12. Epel ES, Blackburn EH, Lin J, Dhabhar FS, Adler NE, Morrow JD. Accelerated telomere shortening in response to life stress. PNAS 2004, 101:17312-17315.
13. Brieger K, Schiavone S, Miller FJ, Krause KH. Reactive oxygen species: from health to disease. Swiss Med Wkly 2012, 142:w13659.
14. Von Zglinicki T. Oxidative stress shortens telomeres. Trends Biochem Sci 2002, 27:339-344.
15. Valko M, Leibfritz D, Moncol J, Cronin MTD, Mazur M, Telser J. Free radicals and antioxidants in normal physiological functions and human disease. Int J Biochem Cell B 2007, 39:44-84.
16. Irwin M. Psychoneuroimmunology of depression: clinical implications. Brain Behav Immun 2002, 16:1-16.
17. Lin J, Epel E, Cheon J, Kroenke C, Sinclair E, Bigos M. Analyses and comparisons of telomerase activity and telomere length in human T and B cells: insights for epidemiology of telomere maintenance. J Immunol Methods 2010, 352:71-80.
18. Damjanovic AK, Yang Y, Glaser R, Kiecolt-Glaser JK, Nguyen H, Laskowski B. Accelerated telomere erosion is associated with a declining immune function of caregivers of Alzheimer's disease patients. J Immunol 2007, 179:4249-4254.
19. Beck AT. Beck Depression Inventory. Bellack AS & Hersen M, editors. 2006, Depression 2-4.
20. Hautzinger M, Keller F, Kuehner C. Beck Depression-Inventar 2 (BDI 2) 2006, Testhandbuch. Frankfurt a.M: Harcourt Test Service.
21. Poon SS, Lansdorp PM. Measurements of telomere length on individual chromosomes by image cytometry. Method Cell Biol 2001, 64:69-96.
22. R Core Team R: A Language and Environment for Statistical Computing 2013, Vienna, Austria: R Foundation for Statistical Computing, URL: http://www.R-project.org/, R Core Team.
23. Shapiro SS, Wilk MB. An analysis of variance test for normality (complete samples). Biometrika 1965, 2:591-611.
24. Wilcoxon F. Individual comparisons by ranking methods. Biometrics Bull 1945, 1:80-83.
25. Anderson DR, Burnham KP, Thompson WL. Null hypothesis Testing: Problems, Prevalence, and an Alternative. J Wildlife Manage 2000, 64:912-923.
26. Naliboff BD, Benton D, Solomon GF, Morley JE, Fahey JL, Bloom ET, Makinodan T, Gilmore SL. Immunological changes in young and old adults during brief laboratory stress. Psychosom Med 1997, 53:2.
27. Ju Z, Jiang H, Jaworski M, Rathinam C, Gompf A, Klein C. Telomere dysfunction induces environmental alterations limiting hematopoietic stem cell function and engraftment. Nat Med 2007, 13:742-747.
28. Verhoeven JE, Revesz D, Epel ES, Lin J, Wolkowitz OM, Penninx BWJH. Major depressive disorder and accelerated cellular aging: results from a large psychiatric cohort study. Mol Psychiatr 2013, 1-7.
29. Freeman EW, Sammel MD, Lin H, Nelson DB. Associations of hormones and menopausal status with depressed mood in women with no history of depression. Arch Gen Psychiat 2006, 63:375-382.
30. Hartmann N, Boehner M, Groenen F, Kalb R. Telomere length of patients with major depression is shortened but independent from therapy and severity of the disease. Depress Anxiety 2010, 12:1111-1116.
31. Fava GA, Fabbri S, Sonino N. Residual symptoms in depression: an emerging therapeutic target. Prog Neuro-psychoph 2002, 26:1019-1027.
32. Kennedy N, Paykel ES. Residual symptoms at remission from depression: impact on long-term outcome. J Affect Disorders 2004, 80:135-144.
33. Paykel ES. Remission and residual symptomatology in major depression. Psychopathology 1998, 31:5-14.
34. Lewinsohn PM, Zeiss AM, Duncan EM. Probability of relapse after recovery from an episode of depression. J Abnorm Psychol 1989, 98:107-116.
35. Linton PJ, Dorshkind K. Age-related changes in lymphocyte development and function. Nat Immunol 2004, 5:133-139.
36. Sommershof A, Aichinger H, Adenauer H, Catani C, Boneberg E, Engler H, Elbert T, Groettrup M, Kolassa IT. Substantial reduction of naïve and regulatory T cells following traumatic stress. Brain Behav Immun 2009, 23:1117-1124.
37. Choi J, Fauce SR, Effros RB. Reduced telomerase activity in human T lymphocytes exposed to cortisol. Brain Behav Immun 2008, 22:600-605.
38. Kananen L, Surakka I, Pirkola S, Suvisaari J, Lönnqvist J, Peltonen L. Childhood adversities are associated with shorter telomere length at adult age both in individuals with an anxiety disorder and controls. PLOS ONE 2010, 5:e10826.
39. Takubo K, Aida J, Izumiyama-Shimomura N, Ishikawa N, Sawabe M, Kurabayashi R. Changes of telomere length with aging. Geriatr Gerontol Int 2010, 10:197-206.
40. Okuda K, Bardeguez A, Gardner JP, Rodriguez P, Ganesh V, Kimura M. Telomere length in the newborn. Pediatr Res 2002, 52:377-381.